Inactive Instrument

Calendar Beigene Ltd Hong Kong S.E.

Equities

End-of-day quote Hong Kong S.E.
- HKD 0.00% Intraday chart for Beigene Ltd

Chart calendar Beigene Ltd

47.wXXS18NoyILwxlk2cSU6oFksuSStcZ818NS-PuP-JhI.r0zip6gBivuJlWluAXJLyS916FGZSa5BiJnmVIrGcCKpNqemtD_l8YL0Ng~f0cd0d7dd80c4dd5c622269987bfb2f9

Upcoming events on Beigene Ltd

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-08-22 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-25 Q4 2024 Earnings Release (Projected)

Past events on Beigene Ltd

2024-03-11 10:00 am Leerink Partners Global Biopharma Conference
2024-03-07 Investor Meeting
2024-03-05 09:50 am TD Cowen Health Care Conference
2024-02-26 06:00 am Q4 2023 Earnings Release
2024-02-25 Q4 2023 Earnings Release
2024-01-08 04:30 pm JPMorgan Healthcare Conference
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 5155
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 5137
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 5163
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 5143
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 4401
2023-12-11 07:30 pm American Society of Hematology Meeting - Abstract No - 1011
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 5144
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No - 4655
2023-12-10 11:00 pm American Society of Hematology Meeting
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No - 3043
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No - 3279
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No - 3032
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract No - 1682
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract No - 2337

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
428
445
-3.82%
309
337
-8.35%
1 176
1 198
-1.84%
1 416
1 420
-0.32%
2 459
2 414
1.87%

3 081

EBITDA
Million USD
Released
Forecast
Spread
-941
-685
-37.4%
-1 626
-1 453
-11.9%
-1 392
-1 201
-15.88%
-1 723
-1 678
-2.69%
-1 120
-1 105
-1.38%

-782

EBIT
Million USD
Released
Forecast
Spread
-960
-752
-27.72%
-1 658
-1 525
-8.69%
-1 439
-1 239
-16.11%
-1 790
-1 751
-2.23%
-1 208
-1 161
-3.99%

-919

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-944
-740
-27.53%
-1 618
-1 480
-9.35%
-1 439
-1 253
-14.77%
-1 961
-1 853
-5.82%
-826
-903
8.51%

-863

Net income
Million USD
Released
Forecast
Spread
-949
-750
-26.52%
-1 597
-1 467
-8.88%
-1 413
-1 223
-15.55%
-2 004
-1 832
-9.4%
-882
-911
3.23%

-874

EPS
USD
Released
Forecast
Spread
-15,8
-14,0
-13.18%
-19,1
-17,8
-7.75%
-15,2
-10,0
-52.22%
-19,4
-15,0
-29.66%
-8,45
-8,56
1.3%

-8,53

Announcement Date02/03/2025/02/2125/02/2227/02/2326/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
214
215
-0.28%
420
386
8.92%
307
260
17.76%
342
311
9.81%
388
377
2.7%
380
388
-2.08%
606
723
-16.13%
448
449
-0.36%
595
515
15.5%
1 043
946
10.32%
781
578
35.12%
634
638
-0.61%

681


757


809


852


785

EBITDA
Million USD
Released
Forecast
Spread
-559
-114
-391.04%



-427
-247
-72.78%
-424
-310
-36.86%
-422
-355
-18.83%
-451
-442
-1.91%



-351
-346
-1.55%






-112
-232
51.55%
-565
-304
-86.18%

-268


-214


-247


-70,6


-68,1

EBIT
Million USD
Released
Forecast
Spread
-572
-463
-23.48%



-443
-456
2.88%
-439
-397
-10.61%
-438
-391
-12.08%
-469
-472
0.67%
-907
-1 086
16.48%
-371
-373
0.58%
-319
-393
18.97%
-690
-781
11.66%
-134
-345
61.22%
-589
-364
-61.67%

-286


-243


-256


-185


-103

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-587
-473
-24.19%



-421
-494
14.79%
-558
-446
-24.94%
-551
-377
-46.08%
-431
-457
5.77%
-982
-1 075
8.63%
-337
-374
10.01%
-367
-379
3.17%
-704
-729
3.37%
229
-365
162.87%
-351
-441
20.54%

-251


-234


-233


-198




Net income
Million USD
Released
Forecast
Spread
-586
-486
-20.55%
-1 000
-925
-8.05%
-434
-519
16.3%
-571
-370
-54.36%
-558
-396
-40.84%
-445
-456
2.24%
-998
-1 105
9.67%
-348
-403
13.62%
-381
-381
0.04%
-730
-752
2.92%
215
-376
157.31%
-368
-431
14.81%

-254


-239


-233


-214




EPS
USD
Released
Forecast
Spread
-6,16
-4,99
-23.36%



-4,24
-5,32
20.35%
-5,56
-4,11
-35.12%
-5,39
-3,85
-40.04%
-4,29
-4,19
-2.47%



-3,34
-3,82
12.45%
-3,64
-3,53
-2.98%



2,01
-3,28
161.25%
-3,48
-4,03
13.68%

-2,80


-2,40


-2,10


-1,77




Announcement Date25/02/2225/02/2205/05/2204/08/2209/11/2227/02/2327/02/2304/05/2302/08/2302/08/2309/11/2326/02/24-----